Literature DB >> 26591693

Health related quality of life: is it another comprehensive evaluation indicator of Chinese medicine on acquired immune deficiency syndrome treatment?

Zhibin Liu, Jiping Yang.   

Abstract

Health related quality of life (HRQOL) can better reflect changes in acquired immune deficiency syndrome (AIDS) patients and inform economic evaluation of AIDS treatment services, and the assessment of HRQOL can help us to detect problems that may influence the progression of the disease, hence HRQOL has become a particularly important assessment indictor for HIV comprehensive interventions. Being a multi-angle, multi-level, and diversified complex intervention, roles of Chinese medicine (CM) in AIDS treatment have been recognized and accepted by more and more patients, and HRQOL has been widely used to evaluate the comprehensive management effects of CM on AIDS. In this article, the authors analyze the definition and measurement of HRQOL, measurement of HRQOL of HIV/AIDS patients and effects of CM on AIDS, and give some reasonable advices for the usage of the scale of HRQOL. The authors hold that some new HRQOL instruments specific for CM treatment of AIDS should be developed and further prospective studies should be carried out to demonstrate the practicality, reliability and validity of HRQOL as an evaluation indictor for CM treatment of AIDS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26591693     DOI: 10.1016/s0254-6272(15)30146-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

Review 1.  Effectiveness and safety of traditional Chinese medicine in treating acquired immune deficiency syndrome: 2004-2014.

Authors:  Zhi-Bin Liu; Ji-Ping Yang; Li-Ran Xu
Journal:  Infect Dis Poverty       Date:  2015-12-23       Impact factor: 4.520

2.  Relationship between health literacy and quality of life among cancer survivors in China: a cross-sectional study.

Authors:  Juan Xia; Peng Wu; Qinglong Deng; Rui Yan; Renren Yang; Binghui Lv; Jiwei Wang; Jinming Yu
Journal:  BMJ Open       Date:  2019-12-31       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.